LakeShore Biopharma Co. L...

NASDAQ: LSB · Real-Time Price · USD
0.79
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
0.79
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

LakeShore Biopharma Ltd Balance Sheet Statement

Financials in CNY. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Cash & Equivalents
246.35M 370.11M 885.2K 390.46M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a 200.01M -345.21M
Other Long-Term Assets
34.36M 20.92M -648.76M 91.37K
Receivables
447.15M 463.05M 308.56M 248.12M
Inventory
203.42M 185.38M 166.51M 81.44M
Other Current Assets
358.87K 576.81K 7.99M 74.51K
Total Current Assets
903.17M 1.04B 1.03M 733.2M
Property-Plant & Equipment
480.62M 582.89M 565M 253.45M
Goodwill & Intangibles
71.25M 78.06M 80.72M 83.78M
Total Long-Term Assets
609.86M 683.77M 200.01M 91.37K
Total Assets
1.51B 1.72B 201.03M 91.37K
Account Payables
67.77M 80.44M 30.81M 16.38M
Deferred Revenue
2.02M 2.3M 2.3M 2.12M
Short-Term Debt
318.54M 193.74M 111.73M n/a
Other Current Liabilities
119.31M 108.8M -381.24M 48.73M
Total Current Liabilities
802.23M 658.76M 142.63K 70.01K
Long-Term Debt
98.98M 293.79M 253.93M 1.1M
Other Long-Term Liabilities
4.55M 8.79M -274.38M 1.29B
Total Long-Term Liabilities
125.6M 332.54M 20.21M 1.33B
Total Liabilities
927.82M 991.3M 20.35M 70.01K
Total Debt
424.46M 498.63M 380.59M 5.01K
Common Stock
26.11K 12.3K 575.00 575.00
Retained Earnings
-2.31B -1.87B -19.32M -3.64K
Comprehensive Income
-58.18M -54.41M 83.09M 44.22M
Shareholders Equity
585.21M 728.45M 180.68M 21.36K
Total Investments
n/a n/a 200.01M -345.21M